Skip to main content
Smart Investors Daily
Cigna Corporation logo

NASDAQ · CI

Cigna Corporation

Healthcare · Medical - Healthcare Plans

$273.04

Down-$12.33 (-4.32%)

Updated Nov 20, 2026, 2:20 AM

SID Score

7.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
72.73B
P/E ratio
11.79
Dividend yield
2.21%
52-week range
$257.85 – $318.05
Volume
3.65M
Avg. volume
1.95M

Price performance · CI

CI price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

CI closed at $273.04 after 21 trading sessions, down 13.56% for the selected period.

Last close
$273.04
Period change
-13.56%
Period low
$273.04
Period high
$315.88
Daily close
View OHLC price history
CI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$284.22$285.08$267.22$273.043.65M
Nov 18, 2026$292.50$294.06$283.02$285.372.49M
Nov 17, 2026$297.16$298.45$292.69$294.061.53M
Nov 16, 2026$301.80$303.65$298.115$300.161.33M
Nov 13, 2026$298.80$298.80$292.28$297.001.44M
Nov 12, 2026$303.56$304.125$294.90$296.271.62M
Nov 11, 2026$300.73$302.22$293.21$301.451.47M
Nov 10, 2026$297.00$303.185$295.65$303.131.49M
Nov 9, 2026$295.00$298.05$291.57$295.601.88M
Nov 6, 2026$293.47$297.30$292.35$293.592.43M
Nov 5, 2026$318.00$318.05$299.665$301.482.77M
Nov 4, 2026$301.96$307.11$296.50$305.412.43M
Nov 3, 2026$293.72$297.68$293.21$295.441.86M
Nov 2, 2026$300.47$300.50$291.93$295.191.51M
Oct 30, 2026$302.79$303.425$297.38$298.231.86M
Oct 29, 2026$300.84$300.90$295.44$298.411.27M
Oct 28, 2026$296.04$299.54$294.115$295.001.02M
Oct 27, 2026$304.68$306.74$297.00$298.281.36M
Oct 26, 2026$307.09$310.95$304.45$305.781.79M
Oct 23, 2026$314.75$315.86$305.51$306.951.78M
Oct 22, 2026$305.73$316.265$304.675$315.881.58M

Latest CI news

The latest Smart Investors Daily articles mentioning CI.

CI research

Overview

Company profile and research snapshot.

Company profile

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$333.00
Implied upside
—
Analysts
16
CI recent ratings
DateFirmRatingTarget
Nov 13, 2026Wells FargoEqual-Weight—
Nov 12, 2026Piper SandlerOverweight—
Nov 12, 2026JefferiesHold—
Nov 11, 2026BernsteinOutperform—
Nov 9, 2026BarclaysEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 13, 2026

Learn Why The Bull Case For Cigna Group (CI) Could Change Following Higher EPS Outlook

Cigna Group reported third quarter 2026 revenue of US$73,683 million and net income of US$1,442 million, and projected 10% to 14% annual adjusted EPS growth through 2030 supported by a US$3 billion modernization and productivity program. The Specialty and Care Services unit generated stronger pre tax adjusted income through wider use of lower cost biosimilars and specialty generics, which now sits alongside long term earnings guidance as a key pillar of Cigna Group’s business story. This...

Yahoo · Nov 12, 2026

Cigna Group (CI): Raised Forecast, Long Runway and a Spot in CIBC’s Defensive Basket

Our new list of the 10 Best Stocks to Buy After Democrats’ Election Sweep, According to CIBC is live, and Cigna Group (NYSE:CI) ranks 9th on it. CIBC Capital Markets recommended a list of top stock picks after the Democratic sweep of Congress, according to CNBC, citing a potentially tougher regulatory environment for corporate America. […]

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.